Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents
Clinical trial NCT06120491 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06120491
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-21
- Primary completion
- 2027-09-30
- Enrollment
- 1898
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.